ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN
Aim. To study efficacy and tolerability of antihypertensive therapy with enalapril (Berlipril®, Berlin-Chemie AG/Menarini Group) and diltiazem (Altiazem® PP, Berlin-Chemie AG/Menarini Group) in postmenopausal women with arterial hypertension (HT) and climacteric disorders.Material and methods. 60 po...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1138 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227724363661312 |
|---|---|
| author | A. A. Kirichenko Z. M. Tankieva |
| author_facet | A. A. Kirichenko Z. M. Tankieva |
| author_sort | A. A. Kirichenko |
| collection | DOAJ |
| description | Aim. To study efficacy and tolerability of antihypertensive therapy with enalapril (Berlipril®, Berlin-Chemie AG/Menarini Group) and diltiazem (Altiazem® PP, Berlin-Chemie AG/Menarini Group) in postmenopausal women with arterial hypertension (HT) and climacteric disorders.Material and methods. 60 postmenopausal women (aged 56,8±3,9 y.o.) with HT of 1-3 degrees were included into the study. They were split in two groups. Patients of the first group (30 people) received enalapril (Berlipril®) 20 mg/daily, patients of the second group (30 people) – diltiazem (Altiazem® PP) 180-360 mg/daily. Observation period was 6 months. Ambulatory blood pressure monitoring (ABPM) was performed before treatment and after 3 weeks, 1, 3 and 6 months of therapy. Climacteric syndrome severity and urodynamic disorders was estimated as well as psychic status according to score of depression and anxiety.Results. Office and ambulance blood pressure decreased after 6 months of therapy in all patients of both groups. A number of complaints on headache and giddiness reduced significantly. Severity of climacteric syndrome also decreased. Enalapril (Berlipril®) monotherapy and especially combined therapy with hydrochlorothiazide led to aggravation of urodinamic disorders. On the contrary both monotherapy with diltiazem (Altiazem® PP) or its combination with hydrochlorothiazide had positive effect on urodinamics. Both therapies reduced depression and anxiety levels significantly.Conclusion. All spectrum of pharmacology effects should be taken into account during antihypertensive therapy of patients with climacteric disorders. |
| format | Article |
| id | doaj-art-5a3b4764f5b54f5585d202cf973d67ea |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-5a3b4764f5b54f5585d202cf973d67ea2025-08-23T10:00:26ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0144545810.20996/1819-6446-2008-4-4-54-581137ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMENA. A. Kirichenko0Z. M. Tankieva1Russian Medical Academy of Postgraduate Educational, Barrikadnaya ul. 2/1, 123995 MoscowRussian Medical Academy of Postgraduate Educational, Barrikadnaya ul. 2/1, 123995 MoscowAim. To study efficacy and tolerability of antihypertensive therapy with enalapril (Berlipril®, Berlin-Chemie AG/Menarini Group) and diltiazem (Altiazem® PP, Berlin-Chemie AG/Menarini Group) in postmenopausal women with arterial hypertension (HT) and climacteric disorders.Material and methods. 60 postmenopausal women (aged 56,8±3,9 y.o.) with HT of 1-3 degrees were included into the study. They were split in two groups. Patients of the first group (30 people) received enalapril (Berlipril®) 20 mg/daily, patients of the second group (30 people) – diltiazem (Altiazem® PP) 180-360 mg/daily. Observation period was 6 months. Ambulatory blood pressure monitoring (ABPM) was performed before treatment and after 3 weeks, 1, 3 and 6 months of therapy. Climacteric syndrome severity and urodynamic disorders was estimated as well as psychic status according to score of depression and anxiety.Results. Office and ambulance blood pressure decreased after 6 months of therapy in all patients of both groups. A number of complaints on headache and giddiness reduced significantly. Severity of climacteric syndrome also decreased. Enalapril (Berlipril®) monotherapy and especially combined therapy with hydrochlorothiazide led to aggravation of urodinamic disorders. On the contrary both monotherapy with diltiazem (Altiazem® PP) or its combination with hydrochlorothiazide had positive effect on urodinamics. Both therapies reduced depression and anxiety levels significantly.Conclusion. All spectrum of pharmacology effects should be taken into account during antihypertensive therapy of patients with climacteric disorders.https://www.rpcardio.online/jour/article/view/1138arterial hypertensionpostmenopauseclimacteric syndromeurodinamic disorders |
| spellingShingle | A. A. Kirichenko Z. M. Tankieva ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN Рациональная фармакотерапия в кардиологии arterial hypertension postmenopause climacteric syndrome urodinamic disorders |
| title | ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN |
| title_full | ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN |
| title_fullStr | ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN |
| title_full_unstemmed | ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN |
| title_short | ANTIHYPERTENSIVE THERAPY AND CLIMACTERIC DISORDERS IN POSTMENOPAUSAL WOMEN |
| title_sort | antihypertensive therapy and climacteric disorders in postmenopausal women |
| topic | arterial hypertension postmenopause climacteric syndrome urodinamic disorders |
| url | https://www.rpcardio.online/jour/article/view/1138 |
| work_keys_str_mv | AT aakirichenko antihypertensivetherapyandclimactericdisordersinpostmenopausalwomen AT zmtankieva antihypertensivetherapyandclimactericdisordersinpostmenopausalwomen |